Market Introduction
Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly. With the advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.
Thus, the significant increase in research and development activities is expected to create a significant demand for medical enzyme technology in the coming years, which is further anticipated to drive the medical enzyme technology market.
Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. European countries are observing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than during the first wave earlier this year. Lockdowns are being reintroduced in the UK, Spain, Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Meanwhile, Europe is attempting to rebound from the COVID-19 crises' impact on citizens' health and its economy's stability. New policies in the European Green Deal would try to mitigate the pandemic's effects. Biotechnology can be a valuable tool in this recovery, from modern plant breeding methods that help us meet the goals of the Farm to Fork Strategy to pharmaceutical and medical innovations that allow us to stop the pandemic. Biotechnology in agriculture has improved animal nutrition, developed vaccines for animals, and improved diagnostics for BSE, foot-and-mouth disease, and salmonella. It has also made it possible to use enzymes. Hence, the European genomic market is likely to show significant growth prospects during this pandemic and forecasted year.
Market Overview and Dynamics
The Medical enzyme technology market in Europe is expected to grow from US$ 1,164.5 million in 2021 to US$ 1,799.6 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. Biopharmaceuticals are among the growing business segments of the pharmaceutical and biotechnology industries. Since their introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of a broad spectrum of diseases, and they are increasingly used in nearly all medicine branches. Despite the immense time and financial effort required, the market of biopharmaceuticals is rapidly growing.
Key Market Segments
In terms of enzyme type, the hydrolases segment accounted for the largest share of the Europe medical enzyme technology market in 2020. In terms of application, the disease treatment segment accounted for the largest share of the Europe medical enzyme technology market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the medical enzyme technology market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Merck Kgaa, Thermo Fisher Scientific Inc., Novozymes, Takeda Pharmaceutical Company Limited, Agilent Technologies, Inc., Genzyme Corporation, Asahi Kasei Corporation, Promega Corporation, Cytiva, and Amano Enzyme Inc.
Reasons to buy report
EUROPE MEDICAL ENZYME TECHNOLOGY MARKET SEGMENTATION
By Enzyme Type
By Application
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,164.5 Million |
| Market Size by 2028 | US$ 1,799.6 Million |
| CAGR (2021 - 2028) | 6.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Enzyme Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Medical Enzyme Technology Market is valued at US$ 1,164.5 Million in 2021, it is projected to reach US$ 1,799.6 Million by 2028.
As per our report Europe Medical Enzyme Technology Market, the market size is valued at US$ 1,164.5 Million in 2021, projecting it to reach US$ 1,799.6 Million by 2028. This translates to a CAGR of approximately 6.4% during the forecast period.
The Europe Medical Enzyme Technology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Medical Enzyme Technology Market report:
The Europe Medical Enzyme Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Medical Enzyme Technology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Medical Enzyme Technology Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Europe Medical Enzyme Technology Market
